Cargando…
Manasanch EE, Han G, Mathur R, et al. A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis. Blood Adv. 2019;3(15):2400-2408.
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759732/ https://www.ncbi.nlm.nih.gov/pubmed/31515233 http://dx.doi.org/10.1182/bloodadvances.2019000881 |
| _version_ | 1783453751625908224 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6759732 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67597322019-09-26 Manasanch EE, Han G, Mathur R, et al. A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis. Blood Adv. 2019;3(15):2400-2408. Blood Adv Erratum American Society of Hematology 2019-09-12 /pmc/articles/PMC6759732/ /pubmed/31515233 http://dx.doi.org/10.1182/bloodadvances.2019000881 Text en © 2019 by The American Society of Hematology |
| spellingShingle | Erratum Manasanch EE, Han G, Mathur R, et al. A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis. Blood Adv. 2019;3(15):2400-2408. |
| title | Manasanch EE, Han G, Mathur R, et al. A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis. Blood Adv. 2019;3(15):2400-2408. |
| title_full | Manasanch EE, Han G, Mathur R, et al. A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis. Blood Adv. 2019;3(15):2400-2408. |
| title_fullStr | Manasanch EE, Han G, Mathur R, et al. A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis. Blood Adv. 2019;3(15):2400-2408. |
| title_full_unstemmed | Manasanch EE, Han G, Mathur R, et al. A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis. Blood Adv. 2019;3(15):2400-2408. |
| title_short | Manasanch EE, Han G, Mathur R, et al. A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis. Blood Adv. 2019;3(15):2400-2408. |
| title_sort | manasanch ee, han g, mathur r, et al. a pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis. blood adv. 2019;3(15):2400-2408. |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759732/ https://www.ncbi.nlm.nih.gov/pubmed/31515233 http://dx.doi.org/10.1182/bloodadvances.2019000881 |